The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study
Aims: The aims of the study were to 1) establish a population pharmacokinetic (Pop-PK) model for busulfan in Chinese pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and then estimate busulfan exposure and 2) explore the association between busulfan exposure and clinical...
Main Authors: | Xiaohuan Du, Chenrong Huang, Ling Xue, Zheng Jiao, Min Zhu, Jie Li, Jun Lu, Peifang Xiao, Xuemei Zhou, Chenmei Mao, Zengyan Zhu, Ji Dong, Xiaoxue Liu, Zhiyao Chen, Shichao Zhang, Yiduo Ding, Shaoyan Hu, Liyan Miao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.905879/full |
Similar Items
-
External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
by: Huiping Huang, et al.
Published: (2022-07-01) -
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
by: Adrin Dadkhah, et al.
Published: (2022-05-01) -
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
by: Sylvain Goutelle, et al.
Published: (2022-10-01) -
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
by: Praveen Shukla, et al.
Published: (2020-07-01) -
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
by: Liu Hui, et al.
Published: (2013-02-01)